Cargando…
Combination siRNA therapy against feline coronavirus can delay the emergence of antiviral resistance in vitro
Virulent biotypes of feline coronavirus (FCoV), commonly referred to as feline infectious peritonitis virus (FIPV), can result in the development of feline infectious peritonitis (FIP), a typically fatal immune mediated disease for which there is currently no effective antiviral treatment. We previo...
Autores principales: | McDonagh, Phillip, Sheehy, Paul A., Norris, Jacqueline M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117502/ https://www.ncbi.nlm.nih.gov/pubmed/25596968 http://dx.doi.org/10.1016/j.vetmic.2014.12.009 |
Ejemplares similares
-
Antiviral effect of mefloquine on feline calicivirus in vitro
por: McDonagh, Phillip, et al.
Publicado: (2015) -
In vitro inhibition of feline coronavirus replication by small interfering RNAs
por: McDonagh, Phillip, et al.
Publicado: (2011) -
Identification and characterisation of small molecule inhibitors of feline coronavirus replication
por: McDonagh, Phillip, et al.
Publicado: (2014) -
Seroprevalence of feline immunodeficiency virus and feline leukaemia virus in Australia: risk factors for infection and geographical influences (2011–2013)
por: Westman, Mark E, et al.
Publicado: (2016) -
Intranasal Delivery of Antiviral siRNA
por: Barik, Sailen
Publicado: (2010)